Salic, Sainoden T.

HRN: 21-45-00  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2022
CEFUROXIME 750MG (VIAL)
06/03/2022
06/09/2022
IV
750mg
Q8
Wound Prophylaxis

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Guideline Not Available